Robert A. Wise

61.4k total citations · 5 hit papers
884 papers, 35.8k citations indexed

About

Robert A. Wise is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pharmacology. According to data from OpenAlex, Robert A. Wise has authored 884 papers receiving a total of 35.8k indexed citations (citations by other indexed papers that have themselves been cited), including 428 papers in Pulmonary and Respiratory Medicine, 237 papers in Physiology and 188 papers in Pharmacology. Recurrent topics in Robert A. Wise's work include Chronic Obstructive Pulmonary Disease (COPD) Research (283 papers), Asthma and respiratory diseases (194 papers) and Antibiotics Pharmacokinetics and Efficacy (181 papers). Robert A. Wise is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (283 papers), Asthma and respiratory diseases (194 papers) and Antibiotics Pharmacokinetics and Efficacy (181 papers). Robert A. Wise collaborates with scholars based in United States, United Kingdom and Canada. Robert A. Wise's co-authors include Pierre-Paul Rompré, J. M. Andrews, J. M. Andrews, John E. Connett, Fredrick M. Wigley, Solbert Permutt, D. Honeybourne, Richard E. Kanner, Philip L. Smith and J. P. Ashby and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Robert A. Wise

854 papers receiving 33.9k citations

Hit Papers

Brain Dopamine and Reward 1989 2026 2001 2013 1989 2005 2018 1995 2007 500 1000 1.5k

Peers

Robert A. Wise
Tobias Welte Germany
Fernando J. Martínez United States
Rinaldo Bellomo Australia
Tom van der Poll Netherlands
Ping Wang United States
Gordon R. Bernard United States
Robert A. Wise
Citations per year, relative to Robert A. Wise Robert A. Wise (= 1×) peers Jan Brożek

Countries citing papers authored by Robert A. Wise

Since Specialization
Citations

This map shows the geographic impact of Robert A. Wise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Wise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Wise more than expected).

Fields of papers citing papers by Robert A. Wise

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Wise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Wise. The network helps show where Robert A. Wise may publish in the future.

Co-authorship network of co-authors of Robert A. Wise

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Wise. A scholar is included among the top collaborators of Robert A. Wise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Wise. Robert A. Wise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bose, Sonali, Janet T. Holbrook, Nan Lin, et al.. (2025). Clinical Characteristics of Patients With COPD and Comorbid Depression and Anxiety: Data From a National Multicenter Cohort Study. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 12(1). 33–42. 1 indexed citations
2.
Pizzichini, Emílio, et al.. (2024). Run-in periods and treatment outcomes in asthma trials: A narrative review. Contemporary Clinical Trials Communications. 42. 101382–101382. 1 indexed citations
3.
Chipps, Bradley E., Robert S. Zeiger, David A. Beuther, et al.. (2024). Advancing assessment of asthma control with a composite tool. Annals of Allergy Asthma & Immunology. 133(1). 49–56. 4 indexed citations
4.
Yohannes, Abebaw Mengistu, Martino Belvederi Murri, Nicola A. Hanania, et al.. (2022). Depressive and anxiety symptoms in patients with COPD: A network analysis. Respiratory Medicine. 198. 106865–106865. 36 indexed citations
5.
George, M. Patricia, et al.. (2021). A 56-Year-Old Man With Emphysema, Rash, and Arthralgia. CHEST Journal. 160(5). e513–e518.
6.
Fowler, Vance G., Anita Das, Raymond Schuch, et al.. (2020). Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis. Journal of Clinical Investigation. 130(7). 3750–3760. 95 indexed citations
7.
Yohannes, Abebaw Mengistu, Michelle N. Eakin, Janet T. Holbrook, et al.. (2020). Association of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study. Expert Review of Respiratory Medicine. 15(1). 153–159. 14 indexed citations
8.
Siddharthan, Trishul, Adaeze C. Wosu, Suzanne L. Pollard, et al.. (2020). <p>A Novel Case-Finding Instrument for Chronic Obstructive Pulmonary Disease in Low- and Middle-Income Country Settings</p>. International Journal of COPD. Volume 15. 2769–2777. 10 indexed citations
9.
Wilson, Sandra R., et al.. (2018). Performance of the Asthma Impact on Quality of Life Scale (A-IQOLS) in diverse asthma research populations and demographic subgroups. Journal of Allergy and Clinical Immunology. 143(1). 395–402.e7. 2 indexed citations
10.
Fawzy, Ashraf, Nirupama Putcha, Laura M. Paulin, et al.. (2018). Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts. Respiratory Research. 19(1). 20–20. 28 indexed citations
11.
Abston, Eric, Alejandro P. Comellas, Robert M. Reed, et al.. (2017). Higher BMI is associated with higher expiratory airflow normalised for lung volume (FEF25–75/FVC) in COPD. BMJ Open Respiratory Research. 4(1). e000231–e000231. 19 indexed citations
12.
Calverley, Peter M.A., Kay Tetzlaff, Daniel Dusser, et al.. (2017). Determinants of exacerbation risk in patients with COPD in the TIOSPIR study. International Journal of COPD. Volume 12. 3391–3405. 35 indexed citations
13.
McGrath‐Morrow, Sharon A., Deepti Malhotra, Thomas Lauer, et al.. (2011). Exposure to neonatal cigarette smoke causes durable lung changes but does not potentiate cigarette smoke–induced chronic obstructive pulmonary disease in adult mice. Experimental Lung Research. 37(6). 354–363. 1 indexed citations
14.
Drummond, Michael, Gregory D. Kirk, Jacquie Astemborski, et al.. (2011). Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax. 67(4). 309–314. 74 indexed citations
15.
Han, MeiLan K., Robert A. Wise, Jeanette A. Mumford, et al.. (2009). Prevalence and clinical correlates of bronchoreversibility in severe emphysema. European Respiratory Journal. 35(5). 1048–1056. 39 indexed citations
16.
Scanlon, Paul D., John E. Connett, Robert A. Wise, et al.. (2004). Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II. American Journal of Respiratory and Critical Care Medicine. 170(12). 1302–1309. 83 indexed citations
17.
Wise, Robert A. & E. J. L. Soulsby. (2002). Antibiotic resistance--an evolving problem.. PubMed. 151(13). 371–2. 11 indexed citations
18.
Black, Steven, Henry R. Shinefield, Paula Ray, et al.. (1997). Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project. The Pediatric Infectious Disease Journal. 16(5). 500–503. 46 indexed citations
19.
Wise, Robert A., et al.. (1987). HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis. The American Journal of Medicine. 82(4). 765–771. 23 indexed citations
20.
Brown, Robert, Robert A. Wise, J. Andrews, & Jules C. Hancox. (1982). Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.. Europe PMC (PubMed Central).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026